Skip To Main Content
H. Weiqing on Muck Rack

H. Weiqing

As seen in: Annals of Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to H. Weiqing’s profile

Articles by H. Weiqing

Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study

|
By D. Ye, H. Ahn, Y-S. Pu, H. Weiqing
| Annals of Oncology Verified
Background: In PREVAIL, pts with progressive mCRPC following ADT had significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) on ENZ vs PL (Beer TM et al, N Engl J MED, 2014). In the current study, the efficacy and safety of ENZ vs PL were evaluated in a similar patient population in China, Taiwan, Hong Kong and South Korea. Methods: Pts with asymptomatic/mildly symptomatic progressive mCRPC following ADT were randomised 1:1 to ENZ (160 mg/day) or PL.
Open in Who Shared Issue with article?
Show More